85 related articles for article (PubMed ID: 16283030)
21. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
22. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
[TBL] [Abstract][Full Text] [Related]
23. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Dalos D; Mascherbauer J; Zotter-Tufaro C; Duca F; Kammerlander AA; Aschauer S; Bonderman D
J Am Coll Cardiol; 2016 Jul; 68(2):189-99. PubMed ID: 27386773
[TBL] [Abstract][Full Text] [Related]
24. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
25. Paradoxical response to the vasodilators.
Gould L; Patel S; Gomes GI; Reddy CV
Angiology; 1982 Feb; 33(2):125-30. PubMed ID: 7065456
[TBL] [Abstract][Full Text] [Related]
26. Valve replacement for aortic stenosis with severe congestive heart failure and pulmonary hypertension.
Snopek G; Pogorzelska H; Zielinski T; Rajecka A; Korewicki J; Biederman A; Kotlinski Z
J Heart Valve Dis; 1996 May; 5(3):268-72. PubMed ID: 8793674
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction.
Lloyd JW; Nishimura RA; Borlaug BA; Eleid MF
J Am Coll Cardiol; 2017 Sep; 70(11):1339-1348. PubMed ID: 28882231
[TBL] [Abstract][Full Text] [Related]
28. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
29. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
[TBL] [Abstract][Full Text] [Related]
30. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
[TBL] [Abstract][Full Text] [Related]
31. [Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
Faggiano P; Rusconi C
G Ital Cardiol; 1991 Nov; 21(11):1195-202. PubMed ID: 1809623
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic changes before acute heart failure episodes in patients with advanced systolic left ventricular dysfunction.
Ghio S; Serio A; Mangiavacchi M; Kjellström B; Valsecchi S; Vicini I; Campana C; Gasparini M; Gronda E; Tavazzi L
J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):799-804. PubMed ID: 18607244
[TBL] [Abstract][Full Text] [Related]
35. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Armstrong PW
Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
37. A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure.
Grodin JL; Drazner MH; Dupont M; Mullens W; Taylor DO; Starling RC; Tang WH
Am Heart J; 2015 Jun; 169(6):806-12. PubMed ID: 26027618
[TBL] [Abstract][Full Text] [Related]
38. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
[TBL] [Abstract][Full Text] [Related]
39. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
[TBL] [Abstract][Full Text] [Related]
40. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
